Previous Close | 193.71 |
Open | 191.96 |
Bid | 191.79 x 800 |
Ask | 196.38 x 1000 |
Day's Range | 189.58 - 195.08 |
52 Week Range | 181.36 - 308.15 |
Volume | |
Avg. Volume | 573,954 |
Market Cap | 9.86B |
Beta (5Y Monthly) | 1.33 |
PE Ratio (TTM) | 26.92 |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
WILMINGTON, Mass., March 13, 2023--Charles River launches Apollo, an intuitive customer platform that provides secure cloud-based access to real-time toxicology study data.
WILMINGTON, Mass., March 13, 2023--Charles River Laboratories To Present At Barclays Global Healthcare Conference
WILMINGTON, Mass., March 09, 2023--Charles River Laboratories International, Inc. (NYSE: CRL) today announced the launch of its off-the-shelf pHelper offering, which is designed to secure supply and streamline adeno-associated virus (AAV)-based gene therapy programs from early discovery through commercial manufacturing. It is available immediately in Research Grade (RG), High Quality (HQ), and Good Manufacturing Practice (GMP)-grade.